Respiratory syncytial virus (RSV) is a respiratory infection that has similar symptoms as a cold. But it can be serious for expectant parents who are more at risk for complications from the virus.

Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial ...

Discover the latest insights in the "Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025." This comprehensive report details RSV clinical trial data, including trial ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private ...

Last winter, you might have seen the headlines about rising hospitalizations from respiratory syncytial virus, or RSV. Healthcare providers now have tools to help prevent lower respiratory tract ...

Respiratory syncytial virus (RSV), a common infection in children and senior adults, can also infect nerve cells and trigger inflammation leading to nerve damage, according to a new Tulane ...

released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co ...

Background. Data on how respiratory syncytial virus (RSV) genotypes influence disease severity and host immune responses is limited. Here, we characterized the genetic variability of RSV during 5 ...